SCHEMBL676893

SCHEMBL676893

CC(=CCCS(=O)(=O)O)C(=O)[O-].[Na+]

nearest known ligand 0.33

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CA4 known ✓ P22748 1/20 0.33
CA1 known ✓ P00915 1/20 0.31
PTGS1 known ✓ P23219 1/20 0.30
PDE4A known ✓ P27815 1/20 0.30
LMNA P02545 1/20 0.30
SLC6A6 P31641 1/20 0.30
CYP2C19 P33261 1/20 0.30
BLM P54132 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4162092 1.00 CA4 (0.33) CA4CA1PTGS1PDE4ALMNA
Potassium Ion SCHEMBL5050694 0.98 PTGS1 (0.31) CA4PTGS1PDE4ALMNASLC6A6
Potassium Ion SCHEMBL5050696 0.98 PTGS1 (0.31) CA4PTGS1PDE4ALMNASLC6A6
Lithium Ion SCHEMBL11107854 0.96 PTGS1 (0.30) PTGS1PDE4ALMNASLC6A6CYP2C19
SCHEMBL2511007 0.89 APP (0.34) CA4
SCHEMBL4251605 0.89 APP (0.34) CA4
Potassium Ion SCHEMBL514904 0.86 APP (0.35)
Potassium Ion SCHEMBL514903 0.86 APP (0.35)
Lithium Ion SCHEMBL28840842 0.85 APP (0.34)
Potassium Ion SCHEMBL11801337 0.85 EPHX2 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12509601-B2 Aqueous ink composition for writing instruments MITSUBISHI PENCIL COMPANY, LIMITED (JP) 2025-12-30 US claimed
US-20110309308-A1 COMPOSITE CONDUCTIVE POLYMER COMPOSITION, METHOD OF MANUFACTURING THE SAME, SOLUTION CONTAINING THE COMPOSITION, USE OF THE COMPOSITION SOKEN CHEMICAL & ENGINEERING CO., LTD. (JP) 2011-12-22 US claimed
US-20070056900-A1 Use of copolymers containing n-vinyl lactam for producing functionalized membranes BASF AKTIENGESELLSCHAFT (DE) 2007-03-15 US claimed
US-5969037-A MULTISTAGE EMULSION POLYMERIZATION OF MONOMERS TO FORM PARTICLES WITH A CORE CONTAINING SILYL VINYL MONOMERS WITH VINYL MONOMERS AND A SHELL AND CURING FOR STORAGE STABILITY, WATERPROOFING, DURABILITY AND WHITE GLOSS KANEGAFUCHI CHEMICAL INDUSTRY CO., LTD. (JP) 1999-10-19 US claimed
EP-0842961-A1 COLD CURABLE COMPOSITION Kanegafuchi Chemical Industry Co., Ltd. (JP) 1998-05-20 EP claimed
EP-0621325-B1 Room temperature curing composition KANEGAFUCHI CHEMICAL IND (JP) 1997-12-29 EP claimed
US-5342730-A With mordant and stripping layers EASTMAN KODAK COMPANY (US) 1994-08-30 US claimed
US-5322758-A Integral color diffusion transfer element for large volume development EASTMAN KODAK COMPANY (US) 1994-06-21 US claimed
EP-0590567-A1 Integral color diffusion transfer element for large volume development EASTMAN KODAK COMPANY (US) 1994-04-06 EP claimed
EP-0590565-A1 Image separation system for large volume development EASTMAN KODAK COMPANY (US) 1994-04-06 EP claimed
US-5290634-A Multilayer elements with supports coated with antistatic layer and gelatin MITSUBISHI PAPER MILLS LIMITED (JP) 1994-03-01 US claimed
US-5288745-A Diffusion transfer for color photography; polymeric mordant dye barrier layers EASTMAN KODAK COMPANY (US) 1994-02-22 US claimed
US-4631235-A Bonding method employing composition for improved adhesion of vinylidene chloride latex to ionomer films UNION OIL COMPANY OF CALIFORNIA (US) 1986-12-23 US claimed
US-4319014-A UNDATURATED CARBOXYLIC ACID COPOLYMER WITH UNDATURATED SULFONATE COMONOMER MODIFIED BY A MERCAPTAN UNIROYAL, INC. (US) 1982-03-09 US claimed
JP-4089885-A None JP disclosed
EP-4345140-B1 DISPERSANT, DISPERSION, INK COMPOSITION, AND METHOD FOR PRODUCING SAME Nissin chemical ind co ltd (JP) 2025-06-04 EP disclosed
US-20240124730-A1 DISPERSANT, DISPERSION, INK COMPOSITION, AND METHOD FOR PRODUCING SAME NISSIN CHEMICAL INDUSTRY CO., LTD. (JP) 2024-04-18 US disclosed
EP-0009221-A1 Vinylidene chloride polymer microgels and use thereof for the preparation of coatings THE DOW CHEMICAL COMPANY (US) 1980-04-02 EP disclosed
EP-0006678-A1 Compositions for the treatment of textile materials and the application thereof COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 1980-01-09 EP disclosed
US-3980622-A Polymerizable emulsifying agent and application thereof KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JA) 1976-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12509601-B2 Aqueous ink composition for writing instruments MKI67, TMT1A, IK CA4 3719/4885CA1 3931/4885PTGS1 654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.